News | March 06, 2026
Lonza to set up Global Capability Centre in Hyderabad
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Hyderabad emerged as Lonza’s preferred destination after an extensive global evaluation process
Their findings, published in the journal Nature, reveal that the spines’ unique porous internal structure allows them to convert water movement into measurable electrical signals
Swayam is designed to support elderly patients and their families with seamless access to coordinated medical care
The construction projects, which have already begun, will be finalised gradually from the end of 2027 through 202
The facility is expected to become operational by FY2028-29
The partnership will focus on the ongoing SYNERGY-101 randomized Phase 2 trial for first-line
The Japanese Patent Office has issued a favorable Appeal Decision granting a patent for the use of REQORSA Gene Therapy in combination with PD-L1 antibodies to treat cancer
Arcellx develops innovative immunotherapies for cancer and other incurable diseases
Sugemalimab, developed using CStone’s OmniRat transgenic platform, is a fully human IgG4 monoclonal antibody designed to minimize immunogenicity and toxicity
The Phase 2 trial, conducted through Starton’s Sargon Site Network, is expanding from two to six sites across the U.S.
Subscribe To Our Newsletter & Stay Updated
